Trilogy Capital Inc. Pfizer Inc Transaction History

Trilogy Capital Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 11, 2024	SELL	$26.13 - $33.94 $14,084 - $18,293	-539 Reduced 6.05%	8,363 $240,000
Q3 2023 Oct 16, 2023	SELL	$32.09 - $37.51 $39,021 - $45,612	-1,216 Reduced 12.02%	8,902 $295,000
Q2 2023 Jul 24, 2023	BUY	$36.12 - $41.79 $65,196 - $75,430	1,805 Added 21.71%	10,118 $371,000
Q1 2023 Apr 17, 2023	BUY	$39.39 - $51.28 $71,138 - $92,611	1,806 Added 27.75%	8,313 $339,000
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $67,050 - $87,527	1,606 Added 32.77%	6,507 $333,000
Q3 2022 Oct 21, 2022	BUY	$43.76 - $53.42 $32,207 - $39,317	736 Added 17.67%	4,901 $214,000
Q2 2022 Jul 20, 2022	BUY	$46.53 - $55.17 $193,797 - $229,783	4,165 New	4,165 $218,000
Q1 2019 Apr 17, 2019	SELL	$37.5 - $41.2 $613,200 - $673,702	-16,352 Closed	0 $0
Q4 2018 Jan 15, 2019	SELL	$38.47 - $43.86 $43,624 - $49,737	-1,134 Reduced 6.49%	16,352 $714,000
Q3 2018 Oct 31, 2018	SELL	$34.47 - $41.81 $63,045 - $76,470	-1,829 Reduced 9.47%	17,486 $771,000
Q2 2018 Aug 20, 2018	SELL	$32.98 - $35.16 $1,022 - $1,089	-31 Reduced 0.16%	19,315 $701,000
Q1 2018 May 24, 2018	BUY	$31.91 - $37.02 $617,330 - $716,188	19,346 New	19,346 $687,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Trilogy Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Trilogy Capital Inc. with notifications on news.